HSCS HEARTSCIENCES INC revenue, earnings and financials
For the quarter ended July 31, 2026, HEARTSCIENCES INC reported revenue of $2.10K (up 10.5% from a year earlier), net income of −$3.17M and diluted EPS of n/a; over the last four quarters revenue was $4.52K and net income −$10.3M; for the fiscal year ended April 2026 revenue was $4.32K, down 0.7% on the year before.
HSCS annual revenue and earnings
- Fiscal year ended Apr 2026: revenue $4.32K, gross profit $2.55K, operating income −$8.41M, net income −$9.14M (margin -211666.5%), EPS n/a
- Fiscal year ended Apr 2025: revenue $4.35K, gross profit $2.47K, operating income −$8.35M, net income −$8.77M (margin -201499.5%), EPS −$9.34
- Fiscal year ended Apr 2024: revenue $18.6K, gross profit $12.5K, operating income −$6.31M, net income −$6.61M (margin -35511.9%), EPS −$18.74
- Fiscal year ended Apr 2023: revenue $5.15K, gross profit $2.35K, operating income −$6.11M, net income −$6.35M (margin -123384.3%), EPS −$80.00
- Fiscal year ended Apr 2022: revenue $14.4K, gross profit $6.48K, operating income −$4.71M, net income −$4.83M (margin -33592.6%), EPS −$1.45
HSCS quarterly revenue and earnings
- Quarter ended Jul 31, 2026: revenue $2.10K (up 10.5% year over year), net income −$3.17M, EPS n/a
- Quarter ended Apr 30, 2026 (from the annual report): revenue $0, net income −$2.75M, EPS n/a
- Quarter ended Jan 31, 2026: revenue $0, net income −$1.99M, EPS n/a
- Quarter ended Oct 31, 2025: revenue $2.42K, net income −$2.35M, EPS −$0.85
- Quarter ended Jul 31, 2025: revenue $1.90K, net income −$2.05M, EPS −$1.58
- Quarter ended Apr 30, 2025 (from the annual report): revenue n/a, net income −$2.09M, EPS −$1.86
- Quarter ended Jan 31, 2025: revenue $0 (down 100.0% year over year), net income −$2.54M, EPS −$2.57
- Quarter ended Oct 31, 2024: revenue n/a, net income −$2.08M, EPS −$2.27
- Quarter ended Jul 31, 2024: revenue n/a, net income −$2.05M, EPS −$2.64
- Quarter ended Apr 30, 2024 (from the annual report): revenue n/a, net income −$1.85M, EPS $13.42
- Quarter ended Jan 31, 2024: revenue $14.7K (up 653.8% year over year), net income −$1.64M, EPS −$3.01
- Quarter ended Oct 31, 2023: revenue $3.90K, net income −$1.75M, EPS −$15.92
- Quarter ended Jul 31, 2023: revenue n/a, net income −$1.37M, EPS −$13.23
- Quarter ended Apr 30, 2023 (from the annual report): revenue n/a, net income −$1.63M, EPS −$79.34
- Quarter ended Jan 31, 2023: revenue $1.95K (down 28.8% year over year), net income −$1.34M, EPS −$0.16
- Quarter ended Oct 31, 2022: revenue n/a, net income −$1.81M, EPS −$0.22
- Quarter ended Jul 31, 2022: revenue $3.20K (down 57.2% year over year), net income −$1.57M, EPS −$0.28
- Quarter ended Apr 30, 2022 (from the annual report): revenue n/a, net income −$2.05M, EPS −$0.62
- Quarter ended Jan 31, 2022: revenue $2.74K, net income −$1.24M, EPS −$0.37
- Quarter ended Oct 31, 2021: revenue n/a, net income −$1.03M, EPS −$0.31
HSCS cash flow, buybacks and dividends
- Fiscal year ended Apr 2026: operating cash flow −$7.43M, share buybacks n/a, dividends $0.00 per share
- Fiscal year ended Apr 2025: operating cash flow −$7.41M, share buybacks n/a, dividends $0.00 per share
- Fiscal year ended Apr 2024: operating cash flow −$6.07M, share buybacks n/a
- Fiscal year ended Apr 2023: operating cash flow −$5.77M, share buybacks n/a
- Fiscal year ended Apr 2022: operating cash flow −$3.64M, share buybacks n/a
HSCS balance sheet
- Jun 30, 2026: cash $1.66M, total assets $5.26M, total liabilities $5.04M, shareholders' equity $226K
- Apr 30, 2026: cash $1.66M, total assets $5.26M, total liabilities $5.04M, shareholders' equity $226K
- Dec 31, 2025: cash $1.10M, total assets $4.22M, total liabilities $4.02M, shareholders' equity $205K
- Oct 31, 2025: cash $1.95M, total assets $6.00M, total liabilities $1.81M, shareholders' equity $4.18M
- Jul 31, 2025: cash $2.79M, total assets $6.44M, total liabilities $3.30M, shareholders' equity $3.14M
- Apr 30, 2025: cash $1.10M, total assets $4.22M, total liabilities $4.02M, shareholders' equity $205K
- Jan 31, 2025: cash $2.60M, total assets $5.70M, total liabilities $3.92M, shareholders' equity $1.79M
- Oct 31, 2024: cash $4.05M, total assets $7.78M, total liabilities $3.76M, shareholders' equity $4.02M
What is HSCS's revenue?
HEARTSCIENCES INC reported $4.52K of revenue over its last four quarters, through July 31, 2026.
Is HSCS profitable?
No. HEARTSCIENCES INC lost $10.3M over the last four quarters.